About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,044 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,044 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5881-5900 of 8,044 trials

RecruitingDyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application DeliveryThe goal of the trial is to test the usability, feasibility and acceptability of an unsupervised, appbased yoga program for participants undergoing thoracic RT and their…NCT06919874·Houston, Texas CompletedPhase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung CancerStudy IPI-504-15 is a Phase 1b/2 clinical trial to evaluate the safety and efficacy of retaspimycin HCl (IPI-504) plus everolimus in patients with KRAS mutant Non-small Cell Lung…NCT01427946·Aurora, Colorado and 4 others CompletedExercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer SurvivorsRATIONALE: Exercise may help improve mobility and relieve fatigue and/or weakness in cancer survivors.NCT00335491·Salt Lake City, Utah CompletedA Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerA study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer in terms of efficacy, safety and tolerabilityNCT02087423·Goodyear, Arizona and 138 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedA Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)This randomized, open-label study was designed to evaluate and compare the safety and efficacy of atezolizumab with gemcitabine + cisplatin or carboplatin in PD-L1 selected…NCT02409355·Encinitas, California and 81 others

Not yet recruitingOsimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell CancerThis phase I trial tests the safety, side effects, and best dose of osimertinib, cetuximab, and tucatinib in treating patients with EFGR-mutant non-small cell lung cancer that is…NCT06067776·Sacramento, California

TerminatedZometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung CancerThe purpose of this study is to evaluate whether the addition of the bisphosphonate Zometa (zoledronic acid) used along with standard regimens of chemotherapy, will help to…NCT01004510·Rochester, New York

UnknownSBRT/RT in Oligometastatic Stage IV NSCLCThe core hypothesis to be tested is that the use of consolidative SBRT followed by maintenance chemotherapy in patients with less than or equal to 10 metastatic sites will improve…NCT05647590·Ostrava, Moravian-Silesian Region

CompletedClinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung CancerThe goal of this observation study is to learn about clinicopathological characteristics and prognostic factors of stage IB NSCLC.NCT05979623·Shanghai

TerminatedStudy of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung CancerThe purpose of this study is to determine whether TH-302 in combination with pemetrexed is safe and effective in the treatment of non-squamous non-small cell lung cancer.NCT02093962·Birmingham, Alabama and 79 others

TerminatedEvaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung CancerThe primary objective for this trial is to determine the biological ability of apricoxib to decrease T reg cells in the peripheral blood and tumor infiltrating lymphocytes in…NCT01532362·Los Angeles, California

Active not recruitingKRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid TumorsThis is a single-center, open-label, single-arm, dose-escalation study aimed at evaluating the safety and preliminary efficacy of KRAS-specific autologous TCR-T cells in patients…NCT06767046·Beijing, Beijing Municipality

UnknownStudy of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerRATIONALE: Studying the proteins expressed in samples of blood and tissue from patients with cancer may help doctors identify biomarkers related to cancer.NCT00989690·Milan

RecruitingPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesBDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability of S241656 as…NCT05786924·Gilbert, Arizona and 48 others

CompletedFirst-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLCThis trial will look at 2 different drug combinations that have well known safety profiles and are known to be active against non small cell lung cancer and combine them with…NCT00456261·Anniston, Alabama and 17 others

Completed13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung CancerRATIONALE: 13 Cis retinoic acid may prevent the development of cancer cells.NCT00002586·Denver, Colorado and 3 others

CompletedTrial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerThe main purpose of this study is to assess the safety, tolerability and anti-tumor activity of the experimental study drug pembrolizumab (also known as Keytruda or MK-3475) in…NCT03087760·Philadelphia, Pennsylvania

TerminatedA Study of ADXS-NEO Expressing Personalized Tumor AntigensThis is a Phase 1, open-label, multicenter study of ADXS-NEO administered alone and in combination with pembrolizumab in participants with select advanced or metastatic solid…NCT03265080·Scottsdale, Arizona and 4 others

CompletedChanges in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung CancerThe purpose of this research study is to evaluate a blood test to measure circulating tumor DNA (ctDNA).NCT03746262·Winston-Salem, North Carolina

CompletedInteractive Voice Response System (IVRS) for Managing Symptoms of Patients Following Thoracic SurgeryTo test the effectiveness of the interactive voice response telephone system with a triage/feedback component that incorporates timely symptom assessment, feedback to physicians…NCT00505024·Houston, Texas

PreviousPage 295 of 403Next